Cythera, Inc.
Records under this name other than patents Cythera, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,633,024 | PDX1 expressing endoderm Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,534,608 | Methods of producing pancreatic hormones Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,993,920 | Methods of producing pancreatic hormones Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,517,901 | Methods of lowering blood glucose levels in a mammal Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,586,357 | Markers of definitive endoderm Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,980,986 | Methods of producing pancreatic hormones Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,173,323 | Methods of using PDX1-positive pancreatic endoderm cells and endocrine precursor cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,254,916 | Methods of making and using PDX1-positive pancreatic endoderm cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,993,916 | Methods for increasing definitive endoderm production Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,585,917 | Methods of producing pancreatic hormones Formerly held In force · From the USPTO record | In force | From the USPTO record |